NCT00099918View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

717

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Trial Locations (2)

07936

Novartis Pharmaceuticals, East Hanover

Unknown

Novartis Investigative Sites, Investigative Centers

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY